This includes the webinar series (presentations, handouts, and the audience QAs recorded from the live broadcast) and CME/CMLE credit.
Series Description: Examining the mutational profile of tumors has become much easier because of the advances and accessibility of next-generation sequencing techniques. Analyzing the genetic signatures of tumors might identify patients who have higher chances of responding to checkpoint inhibition. Various studies have shown how the mutational burden correlates with greater efficacy of anti-PD-L1/PD-1 therapies, however tumor mutational burden (TMB) testing methodology and classification have not yet been standardized in clinical practice. This educational webinar series will provide information regarding current best practices in TMB testing, interpretation, and reporting.
Webinars include: (Click "Topic" tab for descriptions)
Duration: 3 hr
Level of Instruction: Basic
Last day to purchase course and claim credit: June 27, 2019
Maximum CME/CMLE credit available: 3.0
This is a three-part series exploring how measuring tumor mutational burden can improve patient care. If you'd like more information about the series go here.
This program has been supported through an educational grant from Bristol-Myers Squibb.
How to claim credit: To earn CME/CMLE credit, all learners must watch the webinars and then complete the online survey. To access the online survey, click "Submit credit" on the course homepage, or click on "My Credit" on the menu to the left.
AMA PRA Category 1 Credit(s)™
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.
The ASCP designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 3.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.
* You may not submit SAMs and CME/CMLE credit for the same content.
You may also be interested in:
Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
September 26, 2018
American Medical Association
Continuing Medical Education: 3.00
American Society for Clinical Pathology
TMB Series 1 (+CME/CMLE)
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $0.00
Purchase Individual Topics